生理药代动力学建模 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "生理药代动力学建模" in Chinese language version.

refsWebsite
Global rank Chinese rank
2nd place
23rd place
4th place
5th place
11th place
332nd place
6th place
4th place
207th place
628th place
5th place
12th place
1,010th place
2,830th place

archive.org

creativecommons.org

doi.org

doi.org

dx.doi.org

nih.gov

ncbi.nlm.nih.gov

  • Campbell JL J, Clewell RA, Gentry PR, Andersen ME, Clewell HJ 3rd. Physiologically based pharmacokinetic/toxicokinetic modeling. Computational Toxicology, Methods in Molecular Biology Series. Methods in Molecular Biology 929. 2012: 439–499. ISBN 978-1-62703-049-6. PMID 23007440. doi:10.1007/978-1-62703-050-2_18.  温哥华格式错误 (帮助)
  • Jeong, Yoo-Seong; Yim, Chang-Soon; Ryu, Heon-Min; Noh, Chi-Kyoung; Song, Yoo-Kyung; Chung, Suk-Jae. Estimation of the minimum permeability coefficient in rats for perfusion-limited tissue distribution in whole-body physiologically-based pharmacokinetics. European Journal of Pharmaceutics and Biopharmaceutics. 2017, 115: 1–17. PMID 28215648. S2CID 3455193. doi:10.1016/j.ejpb.2017.01.026. 
  • Espié, Pascal; Tytgat, Dominique; Sargentini-Maier, Maria-Laura; Poggesi, Italo; Watelet, Jean-Baptiste. Physiologically based pharmacokinetics (PBPK). Drug Metabolism Reviews. 2009, 41 (3): 391–407. ISSN 1097-9883. PMID 19601719. S2CID 20219523. doi:10.1080/10837450902891360. 
  • Darwich, AS; Pade D; Ammori BJ; Jamei M; Ashcroft DM; Rostami-Hodjegan A. A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution. Journal of Pharmacy and Pharmacology. 2012, 64 (7): 1008–1024. PMID 22686346. S2CID 46066754. doi:10.1111/j.2042-7158.2012.01538.x. 
  • Bouvier d'Yvoire, M.; Prieto P.; Blaauboer B.J.; Bois F.; Boobis A.; Brochot C.; Coecke S.; Freidig A.; Gundert-Remy U.; Hartung T.; Jacobs M. N. Physiologically-based kinetic modelling (PBK modelling): meeting the 3Rs agenda - The report and recommendations of ECVAM Workshop 63a. Alternatives to Laboratory Animals. 2007, 35 (6): 661–671. PMID 18186671. S2CID 1247463. doi:10.1177/026119290703500606.  |author9=|last9=只需其一 (帮助)
  • Peters, SA. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis. Clin Pharmacokinet. 2008, 47 (4): 261–75. PMID 18336055. S2CID 10598918. doi:10.2165/00003088-200847040-00004. 
  • Bois, F.Y. Physiologically-based modelling and prediction of drug interactions. Basic & Clinical Pharmacology & Toxicology. 2009, 106 (3): 154–161. PMID 19912164. doi:10.1111/j.1742-7843.2009.00488.x可免费查阅. 

psu.edu

citeseerx.ist.psu.edu

semanticscholar.org

api.semanticscholar.org

  • Jeong, Yoo-Seong; Yim, Chang-Soon; Ryu, Heon-Min; Noh, Chi-Kyoung; Song, Yoo-Kyung; Chung, Suk-Jae. Estimation of the minimum permeability coefficient in rats for perfusion-limited tissue distribution in whole-body physiologically-based pharmacokinetics. European Journal of Pharmaceutics and Biopharmaceutics. 2017, 115: 1–17. PMID 28215648. S2CID 3455193. doi:10.1016/j.ejpb.2017.01.026. 
  • Espié, Pascal; Tytgat, Dominique; Sargentini-Maier, Maria-Laura; Poggesi, Italo; Watelet, Jean-Baptiste. Physiologically based pharmacokinetics (PBPK). Drug Metabolism Reviews. 2009, 41 (3): 391–407. ISSN 1097-9883. PMID 19601719. S2CID 20219523. doi:10.1080/10837450902891360. 
  • Darwich, AS; Pade D; Ammori BJ; Jamei M; Ashcroft DM; Rostami-Hodjegan A. A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution. Journal of Pharmacy and Pharmacology. 2012, 64 (7): 1008–1024. PMID 22686346. S2CID 46066754. doi:10.1111/j.2042-7158.2012.01538.x. 
  • Bouvier d'Yvoire, M.; Prieto P.; Blaauboer B.J.; Bois F.; Boobis A.; Brochot C.; Coecke S.; Freidig A.; Gundert-Remy U.; Hartung T.; Jacobs M. N. Physiologically-based kinetic modelling (PBK modelling): meeting the 3Rs agenda - The report and recommendations of ECVAM Workshop 63a. Alternatives to Laboratory Animals. 2007, 35 (6): 661–671. PMID 18186671. S2CID 1247463. doi:10.1177/026119290703500606.  |author9=|last9=只需其一 (帮助)
  • Peters, SA. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis. Clin Pharmacokinet. 2008, 47 (4): 261–75. PMID 18336055. S2CID 10598918. doi:10.2165/00003088-200847040-00004. 

worldcat.org